Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Amy Oliver is active.

Publication


Featured researches published by Amy Oliver.


Journal of Biomolecular Screening | 1996

Solution Phase Synthesis of Chemical Libraries for Lead Discovery

Cheryl D. Garr; John R. Peterson; Lauri Schultz; Amy Oliver; Ted L. Underiner; Richard D. Cramer; Allan M. Ferguson; Michael S. Lawless; David E. Patterson

By integrating advanced computational design and synthesis, a series of structurally diverse reaction products based on three core scaffolds were prepared by a propietary high throughput synthesis method. Incorporation of auto-mated work stations and sample handling techniques allowed for the production of more than 20,000 compounds in a relatively short time. A method to efficiently obtain quantitative and qualitative analytical data on these compounds was developed. Structural comparison of the individual members of this library with a database of clinical drug candidates revealed a significant degree of similarity based on Tanimoto coefficients.


Archive | 2009

Inhibitors of human phosphatidylinositol 3-kinase delta

Kenneth O. Dick; Jennifer Treiberg; C. Gregory Sowell; Edward A. Kesicki; Amy Oliver


Archive | 2001

Inhibitors of human phosphatidyl-inositol 3-kinase delta

Kenneth O. Dick; Jennifer Treiberg; C. Gregory Sowell; Edward A. Kesicki; Amy Oliver


Archive | 2005

Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta

Kerry W. Fowler; Danwen Huang; Edward A. Kesicki; Hua Chee Ooi; Amy Oliver; Fuqiang Ruan; Jennifer Treiberg


Archive | 2007

Substituted phenyl acetic acids as dp-2 antagonists

Thomas Dudler; Francine S. Farouz; Kerry W. Fowler; Nataly Hawthorn; Danwen Huang; Jin Bohan; Musong Kim; Andrew Lover; Joshua Odingo; Amy Oliver; Mark Reed; Fuqiang Ruan; Eugene Thorsett


Archive | 2000

PYRAZOLE CYCLIC AMP-SPECIFIC PDE INHIBITORS

Timothy J. Martins; Kerry W. Fowler; Carmen C. Hertel; Amy Oliver


Archive | 2000

Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors

Kerry W. Fowler; Amy Oliver; Joshua Odingo


Archive | 2012

6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta

Kerry W. Fowler; Danwen Huang; Edward A. Kesicki; Hua Chee Ooi; Amy Oliver; Fuqiang Ruan; Jennifer Treiberg; Kamal D. Puri


Archive | 2013

5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta

Kerry W. Fowler; Danwen Huang; Edward A. Kesicki; Hua Chee Ooi; Amy Oliver; Fuqiang Ruan; Jennifer Treiberg; Kamal D. Puri


Archive | 2000

PYRROLIDINE DERIVATIVES AS CYCLIC AMP-SPECIFIC PHOSPHODIESTERASE INHIBITORS

Timothy J. Martins; Kerry W. Fowler; Joshua Odingo; Edward A. Kesicki; Amy Oliver; Laurence Edward Burgess; John Joseph Gaudino; Zachary Jones; Bradley J. Newhouse; Stephen T. Schlachter

Collaboration


Dive into the Amy Oliver's collaboration.

Top Co-Authors

Avatar

Edward A. Kesicki

Infectious Disease Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joshua Odingo

Infectious Disease Research Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge